Adenovector Engineered Interleukin-2 Expressing Autologous Plasma Cell Vaccination After High-Dose Chemotherapy for Multiple Myeloma - A Phase 1 Study

Leukemia - United Kingdom
doi 10.1038/sj.leu.2402077
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC


Related search